Vossler DG - Search Results

1

Treatment of Super-Refractory Status Epilepticus: A Review.

Ochoa JG, Dougherty M, Papanastassiou A, Gidal B, Mohamed I, Vossler DG. Ochoa JG, et al. Among authors: vossler dg. Epilepsy Curr. 2021 Mar 10;21(6):1535759721999670. doi: 10.1177/1535759721999670. Online ahead of print. Epilepsy Curr. 2021. PMID: 33719651 Free PMC article.

2

Summary of Antiepileptic Drugs Available in the United States of America: WORKING TOWARD A WORLD WITHOUT EPILEPSY.

Vossler DG, Weingarten M, Gidal BE; American Epilepsy Society Treatments Committee. Vossler DG, et al. Epilepsy Curr. 2018 Jul-Aug;18(4 Suppl 1):1-26. doi: 10.5698/1535-7597.18.4s1.1. Epilepsy Curr. 2018. PMID: 30233275 Free PMC article. No abstract available.

3

Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.

Vossler DG, Bainbridge JL, Boggs JG, Novotny EJ, Loddenkemper T, Faught E, Amengual-Gual M, Fischer SN, Gloss DS, Olson DM, Towne AR, Naritoku D, Welty TE. Vossler DG, et al. Epilepsy Curr. 2020 Sep;20(5):245-264. doi: 10.1177/1535759720928269. Epub 2020 Aug 21. Epilepsy Curr. 2020. PMID: 32822230 Free PMC article.

4

Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits.

Vossler DG. Vossler DG. Epilepsy Curr. 2022 Jan 12;22(2):120-122. doi: 10.1177/15357597211070392. eCollection 2022 Mar-Apr. Epilepsy Curr. 2022. PMID: 35444497 Free PMC article.

5

Diagnostic Yield and Treatment Changes After Genetic Testing of Adults With Epilepsy.

Vossler DG. Vossler DG. Epilepsy Curr. 2022 Apr 27;22(4):216-218. doi: 10.1177/15357597221098821. eCollection 2022 Jul-Aug. Epilepsy Curr. 2022. PMID: 36187139 Free PMC article. No abstract available.

6

Paxlovid^TM Information From FDA and Guidance for AES Members.

Cokley JA, Gidal BE, Keller JA, Vossler DG; Reviewed and approved by the AES Treatments Committee and Council on Clinical Activities. Cokley JA, et al. Among authors: vossler dg. Epilepsy Curr. 2022 Apr 4;22(3):201-204. doi: 10.1177/15357597221088415. eCollection 2022 Jun. Epilepsy Curr. 2022. PMID: 36451851 Free PMC article.

7

Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus.

Vossler DG. Vossler DG. Epilepsy Curr. 2023 May 4;23(4):230-232. doi: 10.1177/15357597231171240. eCollection 2023 Jul-Aug. Epilepsy Curr. 2023. PMID: 37662457 Free PMC article. No abstract available.

8

Intellectual Disability and Epilepsy: The High Incidence and the Risks of Status Epilepticus and Sudden Death Require Improved Therapies.

Vossler DG. Vossler DG. Epilepsy Curr. 2023 Nov 30;23(6):354-356. doi: 10.1177/15357597231203079. eCollection 2023 Nov-Dec. Epilepsy Curr. 2023. PMID: 38269346 Free PMC article. No abstract available.

9

Is it a Tie at This Point in the Game? Efficacy of Levetiracetam and Phenytoin for the Second-Line Treatment of Convulsive Status Epilepticus.

Vossler DG. Vossler DG. Epilepsy Curr. 2019 Sep;19(5):294-296. doi: 10.1177/1535759719868180. Epub 2019 Aug 21. Epilepsy Curr. 2019. PMID: 31431067 Free PMC article.

10

Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder.

Vossler DG. Vossler DG. Epilepsy Curr. 2022 Sep 22;22(6):348-350. doi: 10.1177/15357597221125238. eCollection 2022 Nov-Dec. Epilepsy Curr. 2022. PMID: 36426195 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page